An identification and functional evaluation of a novel CYP2C9 variant CYP2C962

Warfarin is the most commonly used anticoagulant in the clinical treatment of thromboembolic diseases. The dose of warfarin varies significantly within populations, and the dose is closely related to the genetic polymorphisms of the CYP2C9 and VKORC1 genes. In this study, a new CYP2C9 nonsynonymous...

Full description

Saved in:
Bibliographic Details
Published inChemico-biological interactions Vol. 327; p. 109168
Main Authors Chen, Hao, Dai, Da-Peng, Zhou, Shan, Liu, Jian, Wang, Shuang-Hu, Wu, Hua-Lan, Zhou, Quan, Geng, Pei-Wu, Chong, Jia, Lü, You, Cai, Jian-Ping, Yang, Jie-Fu
Format Journal Article
LanguageEnglish
Published Elsevier B.V 25.08.2020
Subjects
Online AccessGet full text

Cover

Loading…